Top stories






LifestyleMeet South Africa's best-dressed team: Mphela & Associates Attorneys win the 2025 Imagemakers Award
ImageMakers 1 day
More news







Entrepreneurship
AWIEF2025 opens next week in Cape Town











Sanofi-Aventis has told the U.S. Food and Drug Administration its rimonobant antiobesity drug, also sold under the Acomplia brand, brings a higher risk of suicidal thoughts than placebo, and it does not recommend the treatment for patients suffering from major depression.